The main Irish manufacturing arm of Hong Kong stock exchange-listed biopharma firm WuXi Biologics recorded “expected” operating losses of €72.5m last year.In 2023, WuXi...
The outcome of the contest between Donald Trump and the Democratic Party challenger, most likely Kamala Harris, could have huge implications for the tech...